Abstract
Intrahepatic Cholangiocarcinoma (iCCA) is an asymptomatic malignancy of the bile ducts in the liver. The research is predicated on the assumption that a disease is a cluster of genes interacting in a regulatory network and a few driver genes regulating the network. Keeping this in mind, the paper proposes a Gene Median Ratio Clustering (GMRC) algorithm to independently rank the clusters and identify driver genes by hybridizing gene-median ratio (GMR) and gene cluster network (GCN). GMR then employs the Poisson distribution to translate right-skewed data into the Normal distribution and the Anscombe transformation to eliminate data noise and determine the median difference in gene concentration between distinct disease stages. Additionally, hierarchical clustering is separately applied to raw data for gene clustering based on the RNA sequence count. In the process, GMRC is evaluated over the GSE32225 dataset of 155 patients to extract 12 clusters network for proliferation patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used (or will use) ONLY openly available human data that were originally located at: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32225
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
n.puri{at}2022.ljmu.ac.uk, ria46{at}pitt.edu, {vktgtd{at}mst.edu, sdas{at}mst.edu}
Data Availability
All data produced are available online at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32225
